Journal Article
. 2020 Jul;383(3).
doi: 10.1056/NEJMcpc2002422.

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic

Laura M Spring 1 Michelle C Specht 1 Rachel B Jimenez 1 Steven J Isakoff 1 Gary X Wang 1 Amy Ly 1 Jennifer A Shin 1 Aditya Bardia 1 Beverly Moy 1 
  • PMID: 32610007
  •     68 References
  •     2 citations

No abstract available

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Sara M Tolaney, Hao Guo, +23 authors, Eric P Winer.
J Clin Oncol, 2019 Apr 03; 37(22). PMID: 30939096    Free PMC article.
Highly Cited.
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study.
Sara A Hurvitz, Miguel Martin, +18 authors, Dennis Slamon.
J Clin Oncol, 2019 Jun 04; 37(25). PMID: 31157583    Free PMC article.
Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction.
Chirag Shah, Douglas Arthur, +2 authors, Frank A Vicini.
Breast J, 2012 Jul 05; 18(4). PMID: 22759095
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
William J Gradishar, Benjamin O Anderson, +32 authors, Rashmi Kumar.
J Natl Compr Canc Netw, 2020 Apr 08; 18(4). PMID: 32259783
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Norikazu Masuda, Soo-Jung Lee, +18 authors, Masakazu Toi.
N Engl J Med, 2017 Jun 01; 376(22). PMID: 28564564
Highly Cited.
Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial.
A Murray Brunt, Duncan Wheatley, +13 authors, FAST-Forward Trial Management Group.
Radiother Oncol, 2016 Apr 06; 120(1). PMID: 27046390    Free PMC article.
Increase in response rate by prolonged treatment with neoadjuvant letrozole.
J Michael Dixon, Lorna Renshaw, +6 authors, William R Miller.
Breast Cancer Res Treat, 2008 Feb 12; 113(1). PMID: 18264759
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Harry Bartelink, Philippe Maingon, +20 authors, European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups.
Lancet Oncol, 2014 Dec 17; 16(1). PMID: 25500422
Highly Cited.
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), S Darby, +13 authors, R Peto.
Lancet, 2011 Oct 25; 378(9804). PMID: 22019144    Free PMC article.
Highly Cited. Review.
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).
Matthew J Ellis, Vera J Suman, +28 authors, Kelly Hunt.
J Clin Oncol, 2017 Jan 04; 35(10). PMID: 28045625    Free PMC article.
Highly Cited.
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
Benjamin D Smith, Jennifer R Bellon, +13 authors, Reshma Jagsi.
Pract Radiat Oncol, 2018 Mar 17; 8(3). PMID: 29545124
Highly Cited.
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.
Per Karlsson, Bernard F Cole, +8 authors, International Breast Cancer Study Group.
Int J Radiat Oncol Biol Phys, 2010 Aug 24; 80(2). PMID: 20729007    Free PMC article.
First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast Cancer.
Anthony E Dragun, Nicholas J Ajkay, +8 authors, Shiao Y Woo.
Int J Radiat Oncol Biol Phys, 2017 Jun 06; 98(3). PMID: 28581400
Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic.
Davide Mauri, Konstantinos Kamposioras, +3 authors, International Oncology Panel and European Cancer Patient Coalition collaborators.
Lancet Oncol, 2020 May 16; 21(6). PMID: 32410877    Free PMC article.
Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic.
Jonathan M Marron, Steven Joffe, +2 authors, Fay J Hlubocky.
J Clin Oncol, 2020 Apr 29; 38(19). PMID: 32343643
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Adrian Murray Brunt, Joanne S Haviland, +21 authors, FAST-Forward Trial Management Group.
Lancet, 2020 Jun 26; 395(10237). PMID: 32580883    Free PMC article.
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Sibylle Loibl, Joyce O'Shaughnessy, +16 authors, Charles E Geyer.
Lancet Oncol, 2018 Mar 05; 19(4). PMID: 29501363
Highly Cited.
Psychosocial outcomes of breast cancer therapies: lumpectomy versus mastectomy.
D K Wellisch, R DiMatteo, +6 authors, W Schain.
Psychosomatics, 1989 Jan 01; 30(4). PMID: 2798728
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, +58 authors, Håkan Olsson.
JAMA, 2017 Jun 21; 317(23). PMID: 28632866
Highly Cited.
Time interval from breast-conserving surgery to breast irradiation in early stage node-negative breast cancer: 17-year follow-up results and patterns of recurrence.
Olga Vujovic, Edward Yu, +3 authors, Francisco Perera.
Int J Radiat Oncol Biol Phys, 2015 Feb 01; 91(2). PMID: 25636757
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Lancet, 2015 Jul 28; 386(10001). PMID: 26211827
Highly Cited.
Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
Frank A Vicini, Reena S Cecchini, +24 authors, Norman Wolmark.
Lancet, 2019 Dec 10; 394(10215). PMID: 31813636    Free PMC article.
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.
Bernard Fisher, Jong-Hyeon Jeong, +3 authors, Norman Wolmark.
N Engl J Med, 2002 Aug 23; 347(8). PMID: 12192016
Highly Cited.
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer.
Vladimir F Semiglazov, Vladislav V Semiglazov, +7 authors, Lev M Berstein.
Cancer, 2007 Jun 01; 110(2). PMID: 17538978
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer.
G Allevi, C Strina, +15 authors, D Generali.
Br J Cancer, 2013 Apr 13; 108(8). PMID: 23579222    Free PMC article.
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
Timothy J Whelan, Jim A Julian, +19 authors, RAPID Trial Investigators.
Lancet, 2019 Dec 10; 394(10215). PMID: 31813635
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
Fatima Cardoso, Laura J van't Veer, +32 authors, MINDACT Investigators.
N Engl J Med, 2016 Aug 25; 375(8). PMID: 27557300
Highly Cited.
Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study.
E Alba, L Calvo, +10 authors, GEICAM.
Ann Oncol, 2012 Jun 08; 23(12). PMID: 22674146
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.
Jill R Dietz, Meena S Moran, +16 authors, Katharine A Yao.
Breast Cancer Res Treat, 2020 Apr 26; 181(3). PMID: 32333293    Free PMC article.
Highly Cited.
Patient-physician communication in oncology: past, present, and future.
Walter F Baile, Joann Aaron.
Curr Opin Oncol, 2005 Jun 04; 17(4). PMID: 15933462
The safety of multiple re-excisions after lumpectomy for breast cancer.
Suzanne Coopey, Barbara L Smith, +4 authors, Michelle C Specht.
Ann Surg Oncol, 2011 Jun 02; 18(13). PMID: 21630123
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).
A Schneeweiss, S Chia, +10 authors, J Cortés.
Ann Oncol, 2013 May 25; 24(9). PMID: 23704196
Highly Cited.
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +27 authors, George W Sledge.
N Engl J Med, 2018 Jun 05; 379(2). PMID: 29860917    Free PMC article.
Highly Cited.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +28 authors, George W Sledge.
N Engl J Med, 2015 Sep 29; 373(21). PMID: 26412349    Free PMC article.
Highly Cited.
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System.
Vikas Mehta, Sanjay Goel, +16 authors, Amit Verma.
Cancer Discov, 2020 May 03; 10(7). PMID: 32357994    Free PMC article.
Highly Cited.
Approaching difficult communication tasks in oncology.
Anthony L Back, Robert M Arnold, +2 authors, Kelly Fryer-Edwards.
CA Cancer J Clin, 2005 May 14; 55(3). PMID: 15890639
Communication Skills in the Age of COVID-19.
Anthony Back, James A Tulsky, Robert M Arnold.
Ann Intern Med, 2020 Apr 03; 172(11). PMID: 32240282    Free PMC article.
Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
Ian E Smith, Mitch Dowsett, +8 authors, IMPACT Trialists Group.
J Clin Oncol, 2005 Jul 07; 23(22). PMID: 15998903
Highly Cited.
Determinants and Outcomes of Satisfaction With Healthcare Provider Communication Among Cancer Survivors.
Ashish Rai, Xuesong Han, +2 authors, Ahmedin Jemal.
J Natl Compr Canc Netw, 2018 Aug 14; 16(8). PMID: 30099374
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Hongchao Pan, Richard Gray, +9 authors, EBCTCG.
N Engl J Med, 2017 Nov 09; 377(19). PMID: 29117498    Free PMC article.
Highly Cited.
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).
William M Sikov, Donald A Berry, +14 authors, Eric P Winer.
J Clin Oncol, 2014 Aug 06; 33(1). PMID: 25092775    Free PMC article.
Highly Cited.
Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy.
Ivo A Olivotto, Mary L Lesperance, +9 authors, Hagen Kennecke.
J Clin Oncol, 2008 Nov 20; 27(1). PMID: 19018080
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).
Joanne L Blum, Patrick J Flynn, +19 authors, Norman Wolmark.
J Clin Oncol, 2017 Apr 12; 35(23). PMID: 28398846    Free PMC article.
Highly Cited.
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer.
C Palmieri, S Cleator, +19 authors, R C Coombes.
Breast Cancer Res Treat, 2014 Nov 15; 148(3). PMID: 25395314
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
Stephen Jones, Frankie Ann Holmes, +17 authors, Michael A Savin.
J Clin Oncol, 2009 Feb 11; 27(8). PMID: 19204201
Highly Cited.
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.
Hiroji Iwata, Norikazu Masuda, +19 authors, Yasuo Ohashi.
Breast Cancer Res Treat, 2018 Sep 23; 173(1). PMID: 30242578    Free PMC article.
A Survey on Physical and Mental Distress among Cancer Patients during the COVID-19 Epidemic in Wuhan, China.
Yu Qian, Kun Wu, +9 authors, Yuan Wu.
J Palliat Med, 2020 May 16; 23(7). PMID: 32408790
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
Gunter von Minckwitz, Marion Procter, +16 authors, APHINITY Steering Committee and Investigators.
N Engl J Med, 2017 Jun 06; 377(2). PMID: 28581356    Free PMC article.
Highly Cited.
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.
Luca Gianni, Tadeusz Pienkowski, +17 authors, Pinuccia Valagussa.
Lancet Oncol, 2016 May 18; 17(6). PMID: 27179402
Highly Cited.
Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study.
Akiko Chiba, Tanya L Hoskin, +3 authors, Judy C Boughey.
Ann Surg Oncol, 2016 Sep 25; 24(2). PMID: 27663568    Free PMC article.
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.
M J Ellis, A Coop, +9 authors, M Borgs.
J Clin Oncol, 2001 Sep 18; 19(18). PMID: 11559718
Highly Cited.
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.
Jennifer R Bellon, Steven E Come, +5 authors, Abram Recht.
J Clin Oncol, 2005 Mar 19; 23(9). PMID: 15774786
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study.
W Eiermann, S Paepke, +10 authors, Letrozole Neo-Adjuvant Breast Cancer Study Group.
Ann Oncol, 2002 Feb 02; 12(11). PMID: 11822750
Highly Cited.
Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer.
Catherine L Harper-Wynne, Nigel P M Sacks, +14 authors, Mitchell Dowsett.
J Clin Oncol, 2002 Feb 15; 20(4). PMID: 11844826
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
Luigi Cataliotti, Aman U Buzdar, +5 authors, Celia Tosello de Oliveira.
Cancer, 2006 Apr 07; 106(10). PMID: 16598749
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).
FAST Trialists group, Rajiv K Agrawal, +23 authors, John R Yarnold.
Radiother Oncol, 2011 Jul 15; 100(1). PMID: 21752481
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
Gunter von Minckwitz, Chiun-Sheng Huang, +27 authors, KATHERINE Investigators.
N Engl J Med, 2018 Dec 06; 380(7). PMID: 30516102
Highly Cited.
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.
Mitch Dowsett, Ivana Sestak, +7 authors, Jack Cuzick.
J Clin Oncol, 2013 Jul 03; 31(22). PMID: 23816962
Highly Cited.
Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery.
C Pozo, C S Carver, +6 authors, K C Clark.
J Clin Oncol, 1992 Aug 11; 10(8). PMID: 1634919
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
Joseph A Sparano, Robert J Gray, +27 authors, George W Sledge.
N Engl J Med, 2019 Jun 04; 380(25). PMID: 31157962    Free PMC article.
Highly Cited.
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.
Lisa A Carey, Donald A Berry, +15 authors, Clifford A Hudis.
J Clin Oncol, 2015 Nov 04; 34(6). PMID: 26527775    Free PMC article.
Highly Cited.
Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer.
Katsuhiko Nakatsukasa, Hiroshi Koyama, +14 authors, Tetsuya Taguchi.
Breast Cancer, 2016 Jan 13; 24(1). PMID: 26754092
Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.
Laura M Spring, Arjun Gupta, +5 authors, Aditya Bardia.
JAMA Oncol, 2016 Jul 02; 2(11). PMID: 27367583    Free PMC article.
Highly Cited. Systematic Review.
ACR Appropriateness Criteria® Palpable Breast Masses.
Expert Panel on Breast Imaging:, Linda Moy, +13 authors, Mary S Newell.
J Am Coll Radiol, 2017 May 06; 14(5S). PMID: 28473077
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.
Norikazu Masuda, Yasuaki Sagara, +8 authors, Shinzaburo Noguchi.
Lancet Oncol, 2012 Jan 24; 13(4). PMID: 22265697
Accelerated fractionation with a concurrent boost for early stage breast cancer.
Gary M Freedman, Julia R White, +2 authors, Frank A Vicini.
Radiother Oncol, 2013 Jan 22; 106(1). PMID: 23333014
Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement.
Candace Correa, Eleanor E Harris, +5 authors, Jay R Harris.
Pract Radiat Oncol, 2016 Nov 22; 7(2). PMID: 27866865
Highly Cited.
Breast cancer patients with hormone neoadjuvant bridging therapy due to asymptomatic Corona virus infection. Case report, clinical and histopathologic findings.
Marco Pellicciaro, Alessandra Vittoria Granai, +10 authors, Gianluca Vanni.
Int J Surg Case Rep, 2020 Oct 15; 76. PMID: 33052300    Free PMC article.
The Impact of the COVID-19 Pandemic on Breast Imaging.
Phoebe E Freer.
Radiol Clin North Am, 2020 Nov 24; 59(1). PMID: 33222992    Free PMC article.